5HT2C receptor modulator compositions and methods of use

Details for Australian Patent Application No. 2005322183 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Smith, Brian M.; Behan, Dominic P.; Bjenning, Christina

Agent FB Rice

Pub. Number AU-B-2005322183

PCT Pub. Number WO2006/071740

Priority 60/688,901 08.06.05 US; 60/638,667 23.12.04 US

Filing date 21 December 2005

Wipo publication date 6 July 2006

Acceptance publication date 29 March 2012

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/071740 Priority application(s): WO2006/071740

29 March 2012 Application Accepted

  Published as AU-B-2005322183

26 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005322186-Keyless entry touch pad system and method

2005322181-Cross-flow wind turbine